BIZILY SCOTT (Chief Legal Officer) sold 42.7% of their position (2.68K shares) of 4D MOLECULAR THERAPEUTICS, INC. on the open market
Open‑market sale worth $32.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/27/2025ACC: 0001193125-25-251874
Officer· Chief Legal Officer
Since Mar 2022
-2.68K
Net shares
Net seller
$32.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
1.08K acquired · 3.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+1.08K
Price / share
$6.49
Trade value
$7.04K
% of position
20.9%
10/24/2025
5.19K→6.27K
Common Stock
Direct
Shares
−2.68K
Price / share
$12.00
Trade value
$32.14K
% of position
42.7%
10/24/2025
6.27K→3.59K
Total
Net shares
−1.59K
Net value
-$25.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/24/2025 | M · Option Exercise | +1.08K | $6.49 | $7.04K | 20.9% | 5.19K | 6.27K |
| Common Stock Direct | 10/24/2025 | S · Sale | −2.68K | $12.00 | $32.14K | 42.7% | 6.27K | 3.59K |
| Total | −1.59K | -$25.10K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
1.08K shares
Shares
−1.08K
Strike price
6.49
Held after
9.29K
Exercisable
—
10/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock1.08K shares | 10/24/2025 | M · Option Exercise | −1.08K | 6.49 | — | 9.29K |